These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 16714876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
    Mueller J, Mueller E, Hoepner I, Jütting J, Bethke B, Stolte M, Höfler H.
    J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
    [Abstract] [Full Text] [Related]

  • 3. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.
    Yao T, Utsunomiya T, Nagai E, Oya M, Tsuneyoshi M.
    Pathol Int; 1996 Dec; 46(12):962-7. PubMed ID: 9110348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
    Saigusa N, Maruyama K, Sugimura H, Endoh Y, Baba S.
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC, Ginn PE, Homer B, Fox LE, Kurzman ID.
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [Abstract] [Full Text] [Related]

  • 11. MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression.
    Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N.
    Oncology; 1999 Apr; 56(3):223-31. PubMed ID: 10202278
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC, Cologna AJ, Tucci S, Suaid HJ, Falconi RA.
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
    Shimada S, Shiomori K, Tashima S, Tsuruta J, Ogawa M.
    Br J Cancer; 2001 Jun 01; 84(11):1497-504. PubMed ID: 11384100
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma.
    Tsujitani S, Shirai H, Tatebe S, Sugamura K, Ohfuji S, Gomyo Y, Maeta M, Ito H, Kaibara N.
    Cancer; 1996 Apr 15; 77(8 Suppl):1711-6. PubMed ID: 8608567
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas.
    Koga Y, Hirahashi M, Ohishi Y, Oda Y.
    Pathol Int; 2019 Jun 15; 69(6):331-340. PubMed ID: 31282116
    [Abstract] [Full Text] [Related]

  • 17. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
    Yasugi A, Yashima K, Hara A, Koda M, Kawaguchi K, Harada K, Andachi H, Murawaki Y.
    Oncol Rep; 2008 Jan 15; 19(1):41-7. PubMed ID: 18097574
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
    Hao XP, Ilyas M, Talbot IC.
    Pathobiology; 1997 Jan 15; 65(3):140-5. PubMed ID: 9309780
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.